Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin long-term open-label study in partial seizures
NCT00141388Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jul 1998
- Countries
- 2
01
Overview
Phase 3, open-label, single-arm trial of pregabalin in focal seizure, sponsored by Pfizer. Primary endpoints: Safety and Tolerability and Long-term Efficacy. Started Jul 1998; status: completed.
02
Drugs
pregabalin
03
Conditions
focal seizure
Beyond the preview
Go deeper on NCT00141388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00141388.